Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI

Diagnostic and Interventional Radiology

Volumn 13, Issue 3, 2007, Pages 125-128

  Doelken, Marc ^a   Lanz, Stefan ^a   Rennert, Janine ^a   Alibek, Sedat ^a   Richter, Gregor ^a   Doerfler, Arnd ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Diffusion magnetic resonance imaging; Reversible posterior leukoencephalopathy syndrome

Indexed keywords

ALBUMIN; CABERGOLINE; CARBAMAZEPINE; HEPARIN;

ADULT; ARTICLE; BRAIN EDEMA; CASE REPORT; CESAREAN SECTION; CONVULSION; CYTOTOXIC EDEMA; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EDEMA; ELECTROENCEPHALOGRAPHY; FEMALE; HEADACHE; HEMIPARESIS; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; LEUKOCYTE COUNT; LEUKOENCEPHALOPATHY; LOW DRUG DOSE; PATHOLOGICAL ANATOMY; PLEOCYTOSIS; PREECLAMPSIA; PROTEIN CEREBROSPINAL FLUID LEVEL; REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY; SIGNAL DETECTION; TONIC CLONIC SEIZURE; VASOGENIC EDEMA;

ADULT; BRAIN EDEMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; MAGNETIC RESONANCE IMAGING; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD;

EID: 34548455498     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494-500.
2. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000; 356:411-417.
3. Sheth RD, Riggs JE, Bodenstenier JB, Gutierrez AR, Ketonen LM, Ortiz OA. Parietal occipital edema in hypertensive encephalopathy: a pathogenic mechanism. Eur Neurol 1996; 36:25-28.
4. Schneider JP, Krohmer S, Gunther A, Zimmer C. Cerebral lesions in acute arterial hypertension: the characteristic MRI in hypertensive encephalopathy. Rofo 2006; 178:618-626.
5. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996; 335:257-265.
6. Bakshi R, Shaikh ZA, Bates VE, Kinkel PR. Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology 1999; 52:1285-1288.
7. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001; 24:361-364.
8. Taylor MB, Jackson A, Weller JM. Dynamic susceptibility contrast enhanced MRI in reversible posterior leukoencephalopathy syndrome associated with haemolytic uraemic syndrome. Br J Radiol 2000; 73:438-442.
9. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999; 246:339-346.
10. Idilman R, De MN, Kugelmas M, Colantoni A, Van Thiel DH. Immunosuppressive drug-induced leukoencephalopathy in patients with liver transplant. Eur J Gastroenterol Hepatol 1998; 10:433-436.
11. Tweddle DA, Windebank KP, Hewson QC, Yule SM. Cyclosporin neurotoxicity after chemotherapy. BMJ 1999; 318:1113.
12. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000; 21:1199-1206.
13. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002; 23:1038-1048.
14. Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005; 35:83-90.
15. Pavlakis SG, Frank Y, Kalina P, Chandra M, Lu D. Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol 1997; 16:145-148.
16. Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001; 219:756-765.
17. Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998; 51:1369-1376.
18. Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997; 28:1082-1085.
19. Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998; 19:415-417.
20. Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J 2001; 77:24-28.
21. Tajima Y, Isonishi K, Kashiwaba T, Tashiro K. Two similar cases of encephalopathy, possibly a reversible posterior leukoencephalopathy syndrome: serial findings of magnetic resonance imaging, SPECT and angiography. Intern Med 1999; 38:54-58.
22. Sevick RJ, Kanda F, Mintorovitch J, et al. Cytotoxic brain edema: assessment with diffusion-weighted MR imaging. Radiology 1992; 185:687-690.
23. Ahn KJ, Lee JW, Hahn ST, et al. Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol 2003; 76:916-919.
24. Gray L, MacFall J. Overview of diffusion imaging. Magn Reson Imaging Clin N Am 1998; 6:125-138.
25. Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology 1999; 212:333-339.
26. Mak W, Chan KH, Cheung RT, Ho SL. Hypertensive encephalopathy: BP lowering complicated by posterior circulation ischemic stroke. Neurology 2004; 63:1131-1132.
27. Casey SO, Truwit CL. Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy? AJNR Am J Neuroradiol 2000; 21:243-245.